Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
89.21B
Market cap89.21B
Price-Earnings ratio
17.69
Price-Earnings ratio17.69
Dividend yield
5.61%
Dividend yield5.61%
Average volume
14.28M
Average volume14.28M
High today
High today
Low today
Low today
Open price
$44.31
Open price$44.31
Volume
0.00
Volume0.00
52 Week high
$63.33
52 Week high$63.33
52 Week low
$42.96
52 Week low$42.96

BMY News

Nasdaq 21h
Interesting BMY Put And Call Options For December 5th

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options become available today, for the December 5th expiration. At Stock Options Channel , our Yiel...

Interesting BMY Put And Call Options For December 5th
TipRanks 3d
Bristol-Myers Squibb: Hold Rating Amid Market Challenges and Uncertain Growth Prospects

Goldman Sachs analyst Asad Haider maintained a Hold rating on Bristol-Myers Squibb yesterday and set a price target of $51.00. Elevate Your Investing Strategy:...

Nasdaq 4d
Validea Detailed Fundamental Analysis - BMY

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our P/B Growth Invest...

Validea Detailed Fundamental Analysis - BMY

Analyst ratings

69%

of 29 ratings
Buy
27.6%
Hold
69%
Sell
3.4%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.